|
interprofessional education |
28 |
|
partnership model |
28 |
|
social interaction anxiety |
28 |
|
isoprostanes |
9 |
|
bioavailability |
7 |
|
fecal enzyme |
7 |
|
gut microbiota |
7 |
|
l. rhamnosus |
7 |
|
polyunsaturated fatty acid |
7 |
|
soy isoflavone |
7 |
|
antioxidant |
6 |
|
carotenoids |
6 |
|
macular degeneration |
6 |
|
oxidative stress |
5 |
|
saturated fatty acid |
5 |
|
hete |
4 |
|
lipid peroxidation |
4 |
|
ag |
3 |
|
age-related macular degeneration |
3 |
|
atherosclerosis |
3 |
|
carotenoid |
3 |
|
dha |
3 |
|
diabetic retinopathy |
3 |
|
dietary fiber |
3 |
|
fatty acid |
3 |
|
free radicals |
3 |
|
glutathione |
3 |
|
gut metabolism |
3 |
|
humans |
3 |
|
hydroxyeicosatetraenoic acid |
3 |
|
immune system |
3 |
|
inflammation |
3 |
|
microbial metabolites |
3 |
|
myopia |
3 |
|
nanomaterials |
3 |
|
neuroprostanes |
3 |
|
obesity |
3 |
|
omega-6/omega-3 polyunsaturated fatty acid ratio |
3 |
|
polyunsaturated fatty acids |
3 |
|
prebiotics |
3 |
|
transcriptomics |
3 |
|
vitamin e |
3 |
|
zno |
3 |
|
active oxygen. |
2 |
|
adrenic acid |
2 |
|
adult |
2 |
|
alpha-tocopherol - pharmacology |
2 |
|
antigens, cd4 - drug effects |
2 |
|
antigens, cd56 - drug effects |
2 |
|
antigens, cd8 - drug effects |
2 |
|
antioxidants - metabolism - pharmacology |
2 |
|
antioxidants. |
2 |
|
biological markers - metabolism |
2 |
|
biosynthetic pathway |
2 |
|
blood pressure |
2 |
|
cardioprotection |
2 |
|
cell differentiation - drug effects |
2 |
|
cell division - drug effects |
2 |
|
cell membrane permeability - physiology |
2 |
|
cell-mediated immunity |
2 |
|
cells, cultured |
2 |
|
chemotaxonomy |
2 |
|
cholesterol oxidation products |
2 |
|
coral |
2 |
|
diffusion |
2 |
|
drug synergism |
2 |
|
eutrophication |
2 |
|
f4-neuroprostanes |
2 |
|
fatty acid metabolism |
2 |
|
fatty acid ratio |
2 |
|
female |
2 |
|
flow cytometer |
2 |
|
glutathione - metabolism |
2 |
|
hdha |
2 |
|
hetes |
2 |
|
human lymphocyte proliferation |
2 |
|
hydrogen peroxide |
2 |
|
hydrogen peroxide - metabolism |
2 |
|
immunity |
2 |
|
isoprostane |
2 |
|
lactobacillus rhamnosus gg |
2 |
|
lc/ms |
2 |
|
lipid oxidation |
2 |
|
lipids - chemistry |
2 |
|
lipopolysaccharides - toxicity |
2 |
|
lymphocyte subsets - drug effects |
2 |
|
lymphocytes - drug effects - immunology |
2 |
|
male |
2 |
|
medaka fish |
2 |
|
metal oxides |
2 |
|
microarray analysis |
2 |
|
mitogens - toxicity |
2 |
|
nanoparticles |
2 |
|
oat beta‐glucan |
2 |
|
oat bran |
2 |
|
oxidation |
2 |
|
oxidized lipid products |
2 |
|
phytofurans |
2 |
|
phytohemagglutinins - toxicity |
2 |
|
phytoprostanes |
2 |
|
polyphenols |
2 |
|
pork - quality. |
2 |
|
receptors, interleukin-2 - drug effects |
2 |
|
selenium |
2 |
|
selenium - pharmacology |
2 |
|
sonoporation |
2 |
|
stress (physiology) |
2 |
|
swine - carcasses. |
2 |
|
swine - growth. |
2 |
|
trophic level |
2 |
|
vitamins e |
2 |
|
water - metabolism |
2 |
|
water quality |
2 |
|
1-alkyl-2-acetylglycerophosphocholine esterase - genetics - metabolism |
1 |
|
24-hydroxycholesterol |
1 |
|
4‐hhe |
1 |
|
5-lipoxygenase activities |
1 |
|
8-hydroxy-2′-deoxyguanosine |
1 |
|
8-iso-pgf2α |
1 |
|
8-ohdg |
1 |
|
8ohdg |
1 |
|
abts |
1 |
|
acetates - chemistry |
1 |
|
adipose tissue |
1 |
|
administration, oral |
1 |
|
aged |
1 |
|
aged, 80 and over |
1 |
|
aix |
1 |
|
algae |
1 |
|
allantoin |
1 |
|
allantoin - blood |
1 |
|
alpha-linolenic acid |
1 |
|
alpha‐linolenic acid |
1 |
|
animals |
1 |
|
antiarrhythmic |
1 |
|
antioxidant peptide |
1 |
|
antioxidants |
1 |
|
antioxidants - administration & dosage |
1 |
|
antioxidants - analysis - chemistry |
1 |
|
antioxidants - metabolism |
1 |
|
antioxidants - pharmacology |
1 |
|
arachidonic acid - chemistry |
1 |
|
arpe-19 |
1 |
|
arrhythmia |
1 |
|
arrhythmias |
1 |
|
arterial stiffness |
1 |
|
arteries - drug effects |
1 |
|
artifacts |
1 |
|
ascorbic acid - metabolism - pharmacology |
1 |
|
autism spectrum disorder |
1 |
|
basal metabolism |
1 |
|
bioactive |
1 |
|
bioactive lipid mediators |
1 |
|
bioactive lipids |
1 |
|
biological markers - analysis |
1 |
|
biological markers - blood |
1 |
|
biological markers - blood - metabolism - urine |
1 |
|
biological markers - blood - urine |
1 |
|
biological markers - chemistry - metabolism |
1 |
|
biological science |
1 |
|
biological transport, active |
1 |
|
biomarker |
1 |
|
biomarkers |
1 |
|
blood chemical analysis - methods |
1 |
|
blood glucose - drug effects - metabolism |
1 |
|
blood vessels - drug effects - metabolism |
1 |
|
blood viscosity |
1 |
|
body fluids - chemistry |
1 |
|
body mass index |
1 |
|
c-reactive protein - chemistry |
1 |
|
c-reactive protein - genetics - metabolism |
1 |
|
calcium |
1 |
|
camelina sativa oil |
1 |
|
capacitation |
1 |
|
capsaicin |
1 |
|
capsaicin - pharmacology |
1 |
|
capsicum |
1 |
|
carcinoma - blood - radiotherapy - urine |
1 |
|
cardiac arrhythmias |
1 |
|
cardiometabolic disease risk |
1 |
|
cardiovascular diseases |
1 |
|
carotenoids - blood |
1 |
|
casa |
1 |
|
case-control studies |
1 |
|
cell size |
1 |
|
cell wall |
1 |
|
cerebral function |
1 |
|
chlorella - cytology - metabolism |
1 |
|
chlorella sp. |
1 |
|
cholesterol - analogs & derivatives - blood - urine |
1 |
|
cholesterol - blood |
1 |
|
cholesterol - chemistry |
1 |
|
cholesterol, hdl - blood - drug effects |
1 |
|
cholesterol, ldl - blood - drug effects |
1 |
|
chromatography, gel |
1 |
|
chromatography, high pressure liquid |
1 |
|
cigarette smoking |
1 |
|
clinical research |
1 |
|
clinical trial |
1 |
|
compressibility test |
1 |
|
cooking |
1 |
|
cross-over studies |
1 |
|
dengue |
1 |
|
dengue - blood - genetics - physiopathology |
1 |
|
dengue - blood - metabolism - urine |
1 |
|
dengue virus - pathogenicity - physiology |
1 |
|
deoxyadenosines - urine |
1 |
|
deoxyguanosine - analogs & derivatives - analysis |
1 |
|
diabetes mellitus, type 2 - blood - drug therapy - physiopathology |
1 |
|
diet |
1 |
|
dietary supplements |
1 |
|
dihomo-isofurans |
1 |
|
dihomo-isoprostanes |
1 |
|
disease progression |
1 |
|
dna - chemistry |
1 |
|
dose fractionation |
1 |
|
double-blind method |
1 |
|
down syndrome |
1 |
|
electroporation |
1 |
|
epa |
1 |
|
erythrocyte indices |
1 |
|
erythrocyte permeability |
1 |
|
esterified isoprostanes |
1 |
|
exercise |
1 |
|
f 2-isoprostanes |
1 |
|
f2-isoprostane |
1 |
|
f2-isoprostanes |
1 |
|
f2-isoprostanes - analysis |
1 |
|
f2-isoprostanes - analysis - blood - urine |
1 |
|
f2-isoprostanes - analysis - metabolism |
1 |
|
f2-isoprostanes - blood - metabolism - urine |
1 |
|
f2-isoprostanes - blood - urine |
1 |
|
f2-isoprostanes - chemistry |
1 |
|
f2-isoprostanes - chemistry - metabolism |
1 |
|
fatty acid composition |
1 |
|
fatty acid profiles |
1 |
|
fatty acids |
1 |
|
feed intake |
1 |
|
fish |
1 |
|
follow-up studies |
1 |
|
food analysis - methods |
1 |
|
free radical scavengers |
1 |
|
free-isoprostanes |
1 |
|
friedreich ataxia |
1 |
|
garlic |
1 |
|
gas chromatography-mass spectrometry |
1 |
|
gas chromatography-mass spectrometry - methods |
1 |
|
gc-ms |
1 |
|
gc-ms-nci |
1 |
|
gc–ms |
1 |
|
gene expression |
1 |
|
gene expression regulation |
1 |
|
growth phases |
1 |
|
gut fermentation |
1 |
|
hacat |
1 |
|
health benefits |
1 |
|
hemodynamics |
1 |
|
hemoglobin |
1 |
|
hemorheology |
1 |
|
high protein |
1 |
|
human |
1 |
|
human sperm motility |
1 |
|
hydroxycholesterols - blood - metabolism |
1 |
|
hydroxyeicosatetraenoic acid products |
1 |
|
hydroxyeicosatetraenoic acids - analysis - chemistry |
1 |
|
hydroxyeicosatetraenoic acids - blood |
1 |
|
hydroxyeicosatetraenoic acids - blood - metabolism - urine |
1 |
|
hydroxyeicosatetraenoic acids - blood - urine |
1 |
|
hydroxyeicosatetraenoic acids - chemistry |
1 |
|
hypercholesterolemia - blood |
1 |
|
impaired glucose tolerance |
1 |
|
incidence |
1 |
|
ipf 2α |
1 |
|
isapp |
1 |
|
ischemia/reperfusion, n-3 polyunsaturated fatty acids |
1 |
|
isofuranoids |
1 |
|
isofurans |
1 |
|
isoprostanes - analysis |
1 |
|
isoprostanoids |
1 |
|
key structures |
1 |
|
krabbe disease |
1 |
|
lc-ms/ms |
1 |
|
lc–ms/ms |
1 |
|
ldl |
1 |
|
leukodystrophy |
1 |
|
leukotriene b§ssub§4§esub§ |
1 |
|
levodopa - pharmacology |
1 |
|
lipid metabolism |
1 |
|
lipid peroxidation products |
1 |
|
lipidomics |
1 |
|
lipids |
1 |
|
lipids - blood |
1 |
|
lipoproteins, ldl - blood |
1 |
|
liquid chromatography-tandem mass spectrometry |
1 |
|
liver glycogen - metabolism |
1 |
|
loose bulk density |
1 |
|
low-density lipoprotein |
1 |
|
lycopene |
1 |
|
lycopersicon esculentum |
1 |
|
magnetic resonance spectroscopy |
1 |
|
magnetic resonance spectroscopy - methods |
1 |
|
malondialdehyde - blood |
1 |
|
maltol |
1 |
|
mass spectrometry |
1 |
|
mass spectrometry - methods |
1 |
|
mc-fan |
1 |
|
meal frequency |
1 |
|
mecp2 mutation |
1 |
|
medaka |
1 |
|
melanoidin |
1 |
|
microbiome |
1 |
|
microcirculation |
1 |
|
middle aged |
1 |
|
mitochondria |
1 |
|
mitochondrial disorder |
1 |
|
models, biological |
1 |
|
models, structural |
1 |
|
molecular structure |
1 |
|
mptp |
1 |
|
multiple sclerosis |
1 |
|
murine models |
1 |
|
nasal mucosa - secretion |
1 |
|
nasopharyngeal cancer |
1 |
|
nasopharyngeal neoplasms - blood - radiotherapy - urine |
1 |
|
natural history |
1 |
|
neuroblastoma |
1 |
|
neurofurans |
1 |
|
neurological disease |
1 |
|
neurological diseases |
1 |
|
non-alcoholic fatty liver disease |
1 |
|
non-enzymatic metabolites |
1 |
|
nuclear magnetic resonance, biomolecular |
1 |
|
nuts |
1 |
|
ohmic heating |
1 |
|
omega 3 pufas |
1 |
|
omega-3 pufa |
1 |
|
omega‐3 lipids |
1 |
|
oxidation-reduction |
1 |
|
oxidative damage |
1 |
|
oxidative stress - drug effects |
1 |
|
oxidative stress - drug effects - physiology |
1 |
|
oxidative stress - radiation effects |
1 |
|
oxidativestress |
1 |
|
oxygen - chemistry |
1 |
|
oxygenated metabolites |
1 |
|
oxylipin |
1 |
|
oxysterol |
1 |
|
oxysterols |
1 |
|
pan-frying |
1 |
|
parkinson disease |
1 |
|
parkinson disease - blood - diagnosis - pathology |
1 |
|
parkinson disease - blood - metabolism - urine |
1 |
|
peptides - chemistry |
1 |
|
permeability |
1 |
|
pfg-nmr |
1 |
|
pfos |
1 |
|
phenotype |
1 |
|
phospho-ampkα |
1 |
|
placebos |
1 |
|
plant extracts - administration & dosage |
1 |
|
plant extracts - pharmacology |
1 |
|
plasma |
1 |
|
platelet dysfunction |
1 |
|
platelet function |
1 |
|
polymers - chemistry |
1 |
|
powder rheology |
1 |
|
pufa |
1 |
|
pufas |
1 |
|
pulse wave velocity |
1 |
|
pulsed field gradient nmr |
1 |
|
pyrones - chemistry |
1 |
|
quantification |
1 |
|
radiation injuries - blood - epidemiology - urine |
1 |
|
radiotherapy |
1 |
|
radiotherapy - adverse effects |
1 |
|
rainbow trout |
1 |
|
rats |
1 |
|
rats, wistar |
1 |
|
redox homeostasis |
1 |
|
redox pathologies |
1 |
|
redox signaling |
1 |
|
regional blood flow - drug effects |
1 |
|
reproducibility of results |
1 |
|
resveratrol |
1 |
|
rett syndrome |
1 |
|
rice-wine |
1 |
|
rna |
1 |
|
ros |
1 |
|
rosemary |
1 |
|
ryanodine receptor |
1 |
|
saccharomyces cerevisiae |
1 |
|
salmon |
1 |
|
sensitivity and specificity |
1 |
|
skin peroxidation |
1 |
|
smoking - blood - metabolism - urine |
1 |
|
solvents - chemistry |
1 |
|
soy foods |
1 |
|
soy foods - analysis |
1 |
|
soy sauce |
1 |
|
spe |
1 |
|
specimen handling - methods |
1 |
|
spectrometry, mass, electrospray ionization |
1 |
|
sterols - analysis - metabolism |
1 |
|
stroke - blood - metabolism - urine |
1 |
|
thalassemia |
1 |
|
tocopherol |
1 |
|
tomato |
1 |
|
total synthesis |
1 |
|
total-isoprostanes |
1 |
|
triglycerides - blood |
1 |
|
tumor necrosis factor-alpha - genetics - metabolism |
1 |
|
type 2 diabetes |
1 |
|
up-regulation - radiation effects |
1 |
|
urinalysis - methods |
1 |
|
uva |
1 |
|
vascular disease |
1 |
|
vascular function |
1 |
|
vasodilator agents - pharmacology |
1 |
|
virulence |
1 |
|
vitamin c |
1 |
|
walnut |
1 |
|
water diffusion |
1 |
|
water self-diffusion coefficient |
1 |
|
yeast |
1 |
|
yeasts - growth & development - physiology |
1 |
|
zinc |
1 |
|
zinc - administration and dosage - blood |
1 |
|
α-linolenic acid |
1 |
|
ω-3 long chain polyunsaturated fatty acid |
1 |
